The Future of Essential Health Benefits -
Editor's Note: The Essential Health Benefits (EHB) rule may be among the many parts of the Affordable Care Act (ACA) that are on the chopping block as the Trump Administration and...more
3/24/2017
/ Affordable Care Act ,
Antitrust Immunity ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Essential Health Benefits ,
False Claims Act (FCA) ,
Health Insurance ,
Healthcare Reform ,
Insurer Liability ,
Medicaid ,
Premiums ,
Repeal ,
Trump Administration
The Election’s Impact on Healthcare: Preparing for Potential Scenarios -
Editor’s Note: Election 2016 will have a major impact on federal and state healthcare policy. To be prepared for all the possibilities, it’s...more
9/22/2016
/ Affordable Care Act ,
Civil Monetary Penalty ,
Department of Justice (DOJ) ,
False Claims Act (FCA) ,
FCC ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
IPAB ,
Presidential Elections ,
Privacy Policy ,
Risk Mitigation ,
TCPA ,
Telemarketing ,
WhatsApp
Section 1332 Waivers: Will We See More State Innovation? -
Editor's Note: In a new essay for the National Institute of Health Care Management (NIHCM), summarized below, Manatt Health examines Section 1332 waivers and the...more
8/25/2016
/ 1332 Waiver ,
Assisted Suicide ,
Customer-Loyalty Programs ,
Department of Health and Human Services (HHS) ,
Discounts ,
Dispute Resolution ,
False Claims Act (FCA) ,
Federal Trade Commission (FTC) ,
Long Term Care Facilities ,
Medicaid ,
Off-Label Promotion ,
Patient Privacy Rights ,
PHRMA ,
Prescription Drug Coverage ,
Section 340B ,
Unfair or Deceptive Trade Practices
As the Healthcare Landscape Shifts, Four Issues Are Critical to Build Effective Market Access Strategies -
In this time of high growth and fast change for the healthcare industry, pharmaceutical, biotechnology and...more
8/20/2013
/ Affordable Care Act ,
Biotechnology ,
Compliance ,
False Claims Act (FCA) ,
Fraud ,
Health Insurance Exchanges ,
Healthcare ,
Insurance Industry ,
Manufacturers ,
Medical Devices ,
Penalties ,
Pharmaceutical Industry ,
Premiums ,
Prescription Drugs ,
Reimbursements